JAMES DOWD: Open Payments
NPI 1881241958 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 73 payments from 17 companies in 2025. Trend: 2023 $1,494 · 2024 $299 · 2025 $1,539
Food & beverage: $1,512Education: $27
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $252 |
| ABBVIE INC. | 16 | $187 |
| Axsome Therapeutics, Inc. | 9 | $184 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $124 |
| Neurocrine BioSciences, Inc. | 6 | $123 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Janssen Pharmaceuticals, Inc | 5 | $97 |
| Lundbeck LLC | 3 | $86 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
| Tris Pharma Inc | 3 | $55 |
Products named: VRAYLAR, Auvelity, REXULTI, ARISTADA, CAPLYTA, INGREZZA, VIVITROL, SPRAVATO.
Industry payments across NC — which companies pay providers there.
